Join
Live feed
·
PRReleasevia Quantisnow
Biogen Inc. logo
Praxis Precision Medicines Inc. logo
Stoke Therapeutics Inc. logo
+1

GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025

ByQuantisnow·Wall Street's wire, on your screen.
BIIB· Biogen Inc.PRAX· Praxis Precision Medicines Inc.STOK· Stoke Therapeutics Inc.WGS· GeneDx Holdings Corp.
Health CareTechnology
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025 | Quantisnow